A multicentre double blind trial of fluoxetine versus amitriptyline in the treatment of depressive illness

References

• Lemberger L, Fuller R W, Zerbe R L. Use of specific serotonin uptake inhibitors as antidepressants. Clinical Neuropharmacology 1985; 8: 299–317
   PubMed Web of Science ®Google Scholar
• Wong D, Bymaster F P, Horng J S, Molloy B B. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethyl phenoxy)-N-methyl-3-phenyl propylamine. Journal of Pharmacology and Experimental Therapeutics 1975; 193: 804–811
   PubMed Web of Science ®Google Scholar
• Schmidt M J, Fuller R W, Wong D T. Fluoxetine, a highly selective serotonin reuptake inhibitor: a review of preclinical studies. British Journal of Psychiatry 1988; 153(Supplement 3)40–46
   Google Scholar
• Hall J. Fluoxetine: Efficacy against placebo and by dose- an overview. British Journal of Psychiatry 1988; 153: 59–63, (Supplement 3)
   Google Scholar
• Levine S, Deo R, Mahadevan K. A comparative trial of a new antidepressant: fluoxetine. British Journal of Psychiatry 1987; 150: 653–655
   PubMedGoogle Scholar
• Young J PR, Coleman A, Lader M H. A controlled comparison of fluoxetine and amitriptyline in depressed outpatients. British Journal of Psychiatry 1987; 151: 337–340
   PubMedGoogle Scholar
• Bremner J. Fluoxetine in depressed patients: a comparison with imipramine. Journal of Clinical Psychiatry 1984; 45: 414–419
   PubMed Web of Science ®Google Scholar
• Cohn J B, Wilcox C. A comparison of fluoxetine, imipramine and placebo in patients with major depressive disorders. Journal of Clinical Psychiatry 1985; 46: 26–31
   PubMed Web of Science ®Google Scholar
• Feighner J P, Boyer W F, Merideth C H, Hendrickson G. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression. International Clinical Psychopharmacology 1989; 4: 127–134
   PubMedGoogle Scholar
• Chouinard G. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. Journal of Clinical Psychiatry 1985; 46: 32–37
   PubMed Web of Science ®Google Scholar
• Manna V., Martucci N., Agnoli A. Double-blind controlled study on the clinical efficacy and safety of fluoxetine versus clomipramine in the treatment of major depressive disorders. International Clinical Psychopharmacology 1989; 4(Supplement 1)81–88
   PubMedGoogle Scholar
• Ropert R, Bouchard J M, Caroli F, Cotin M, Danic C, Barbier J E, Talgom L., Leroy J P, Rigal J, Binoux F, Delpech J, Delcourt T. Fluoxetine versus clomipramine in major depressive disorders. International Clinical Psychopharmacology 1989; 4: 89–95
   PubMed Web of Science ®Google Scholar
• Ginestel D, Alby J M, Besancon G, Carrier G, Cordier B, Degiovanni A, Dufour H, Ferreri M, Leger L, Moron P, Pellet J, Perivier E., Singer L., Ulliac G. Fluoxetine in endogenous depression and melancholia versus clomipramine. International Clinical Psychopharmacology 1989; 4: 37–40
   PubMedGoogle Scholar
• Cooper G L. The safety of fluoxetine- an update. British Journal of Psychiatry. 1988; 153: 77–86, (Supplement 3)
   Web of Science ®Google Scholar
• Fawcett J, Zajecka J M, Kravitz H M, Edwards J, Jeffries H, Scorza E. Fluoxetine versus amitriptyline in adult outpatients with major depression. Current Therapeutic Research 1989; 45: 821–832
   Web of Science ®Google Scholar
• Feighner J P. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. Journal of Clinical Psychiatry 1985; 46: 369–372
   PubMed Web of Science ®Google Scholar
• Masco H L, Sheetz M S. Double-blind comparison of fluoxetine and amitriptyline in the treatment of major depressive illness. Advances in Therapy 1985; 2: 275–284
   Google Scholar
• Laakmann G, Blaschke D, Engel R, Schwarz A., Fluoxetine V. Amitriptyline in Treatment of Depressed Outpatients. British Journal of Psychiatry 1988; 153(Suppl 3)64–68
   Google Scholar
• Almatura A C, Percudani M, Guercetti G, Invernizzi G. Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitriptyline. International Clinical Psychopharmacology 1989; 4(Suppl 1)103–106
   PubMedGoogle Scholar
• Judd F K. Preliminary report of a double-blind study comparing fluoxetine and amitriptyline in the treatment of depression. In: Recent Advances in the Treatment of Depression. Proceedings from a symposium in Hong Kong. JAMA SE Asia (Suppl) 1991; 6(4)
   Google Scholar
• Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 1967; 6: 278–296
   PubMed Web of Science ®Google Scholar
• Carroll B J, Feinberg M, Smouse P E, Rawson S G., Greden J F. The Carroll Rating Scale for Depression I. Development, Reliability and Validation. British Journal of Psychiatry 1981; 138: 194–200
   PubMed Web of Science ®Google Scholar
• Teicher M H, Glod C, Cole J O. Emergence of intense suicidal pre-occupation during fluoxetine treatment. American Journal of Psychiatry 1990; 147: 207–10
   PubMed Web of Science ®Google Scholar
• Masand P, Gupta S, Dewan M. Suicidal ideation related to fluoxetine treatment. New England Journal of Medicine 1991; 324: 420
   PubMed Web of Science ®Google Scholar
• Clark C, Downie C C. A method for the rapid determination of the number of patients to include in a controlled clinical trial. Lancet 1966; 2: 1357–1358
   PubMedGoogle Scholar
• Beasley C M, Dornseif B E, Bosomworth J C, Sayler M E, Rampey A H, Heiligenstein J H, Thompson V L, Murphy D J, Marica D N. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal 1991; 303: 685–692
   PubMed Web of Science ®Google Scholar